Factors Associated With Survival in Secondary Acute Myeloid Leukemia in Colombia

Claudia Sossa, Virginia Abello (Co-autor), Luis Salazar (Co-autor), Ángela Peña (Co-autor), Henry Idrobo (Co-autor), Jheremy Reyes (Co-autor), William Mantilla (Co-autor), Guillermo Quintero (Co-autor), Rigoberto Gómez (Co-autor), Kenny Galvez (Co-autor), Mario Correa (Co-autor), Paola Guerrero (Co-autor), Lina Gaviria (Co-autor), Carlos Bermudez (Co-autor), Pau Montesinos (Co-autor), Miguel Sanz (Co-autor), Diana Marcela Cuervo (Co-autor)

Producción científica: Artículos / NotasArtículo Científico

Resumen

The management of secondary acute myeloid leukemia (s-AML) is challenging because its characteristics predict a poor prognosis. In Colombia, there is a paucity of evidence regarding outcomes in this subgroup of patients.
Idioma originalInglés
PublicaciónClinical Lymphoma, Myeloma and Leukemia
DOI
EstadoPublicada - 1 sep. 2023

Palabras clave

  • AML
  • acute myeloid leukemia
  • secondary acute myeloid leukemia
  • survival
  • Colombia
  • HSCT
  • allo-HSCT

Líneas de Investigación UNAB

  • Medicina Interna

Citar esto